(Q66401890)
Statements
A Phase I Study of the Mesothelin-Targeted Immunotoxin LMB-100 With or Without Nab-Paclitaxel (Abraxane) in Patients With Malignant Mesothelioma (English)
0 references
10 June 2016
0 references
20 July 2017
0 references
21
0 references
18 year
0 references
100 year
0 references